Prediction of morphine dose in humans

Paediatric Anaesthesia

Volumn 22, Issue 3, 2012, Pages 209-222

  Holford, Nick H G ^a   Ma, Shu C ^a   Anderson, Brian J ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

adults; allometric scaling maturation; children; infants; morphine; pharmacokinetics; premature neonates

Indexed keywords

MORPHINE;

ADOLESCENT; ADULT; AGED; ALLOMETRY; ARTICLE; CHILD; DOSE CALCULATION; DOSE RESPONSE; DRUG CLEARANCE; DRUG HALF LIFE; GROUPS BY AGE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; NEWBORN; PRESCHOOL CHILD; PRIORITY JOURNAL; PUBLICATION; RECOMMENDED DRUG DOSE; SCHOOL CHILD;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ALGORITHMS; ANALGESICS, OPIOID; BODY WEIGHT; CHILD; CHILD, PRESCHOOL; FEMALE; FORECASTING; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; MODELS, STATISTICAL; MORPHINE; PAIN, POSTOPERATIVE; YOUNG ADULT;

EID: 84856249817     PISSN: 11555645     EISSN: 14609592     Source Type: Journal    
DOI: 10.1111/j.1460-9592.2011.03782.x     Document Type: Article

References (67)

1. Bouwmeester NJ, Anderson BJ, Tibboel D, et al. Developmental pharmacokinetics of morphine and its metabolites in neonates, infants and young children. Br J Anaesth 2004; 92: 208-217. (Pubitemid 38159658)
2. Anand KJ, Anderson BJ, Holford NH, et al. Morphine pharmacokinetics and pharmacodynamics in preterm and term neonates: secondary results from the NEOPAIN trial. Br J Anaesth 2008; 101: 680-689.
3. Anand KJ, Hall RW, Desai N, et al. Effects of morphine analgesia in ventilated preterm neonates: primary outcomes from the NEOPAIN randomised trial. Lancet 2004; 363: 1673-1682. (Pubitemid 38670324)
4. West GB, Brown JH, Enquist BJ,. A general model for the origin of allometric scaling laws in biology. Science 1997; 276: 122-126. (Pubitemid 27161259)
5. Tod M, Lokiec F, Bidault R, et al. Pharmacokinetics of oral acyclovir in neonates and in infants: a population analysis. Antimicrob Agents Chemother 2001; 45: 150-157. (Pubitemid 32039107)
6. West GB, Brown JH, Enquist BJ,. The fourth dimension of life: fractal geometry and allometric scaling of organisms. Science 1999; 284: 1677-1679. (Pubitemid 29291379)
7. Savage VM, Deeds EJ, Fontana W,. Sizing up allometric scaling theory. PLoS Comput Biol 2008; 4: e1000171.
8. Tod M, Jullien V, Pons G,. Facilitation of drug evaluation in children by population methods and modelling. Clin Pharmacokinet 2008; 47: 231-243. (Pubitemid 351367434)
9. Anderson BJ, Holford NHG,. Mechanistic basis of using body size and maturation to predict clearance in humans. Drug Metab Pharmacokinet 2009; 24: 25-36.
10. Anderson BJ, Holford NH,. Mechanism-based concepts of size and maturity in pharmacokinetics. Annu Rev Pharmacol Toxicol 2008; 48: 303-332. (Pubitemid 351738156)
11. Rhodin MM, Anderson BJ, Peters AM, et al. Human renal function maturation: a quantitative description using weight and postmenstrual age. Pediatr Nephrol 2009; 24: 67-76.
12. Anderson BJ, Holford NHG,. Tips and traps analyzing pediatric PK data. Pediatr Anesth 2011; 21: 222-237.
13. Sheiner LB, Rosenberg B, Melmon KL,. Modelling of individual pharmacokinetics for computer-aided drug dosage. Comput Biomed Res 1972; 5: 441-459.
14. Sheiner L, Tozer T,. Clinical pharmacokinetics: the use of plasma concentrations of drugs. In:, Melmon K, Morelli H, eds. Clinical Pharmacology: Basic Principles of Therapeutics. New York: Macmillan, 1978: 71-109.
15. Holford NH,. Target concentration intervention: beyond Y2K. Br J Clin Pharmacol 1999; 48: 9-13. (Pubitemid 29296656)
16. Sheiner LB,. The population approach to pharmacokinetic data analysis: rationale and standard data analysis methods. Drug Metab Rev 1984; 15: 153-171. (Pubitemid 14123936)
17. Mahmood I,. Evaluation of a morphine maturation model for the prediction of morphine clearance in children: how accurate is the predictive performance of the model? Br J Clin Pharmacol 2011; 71: 88-94.
18. Anderson BA, Holford NHG,. Evaluation of a morphine maturation model for the prediction of morphine clearance in children. Br J Clin Pharmacol 2011; 72: 518-520.
19. Sheiner LB, Beal SL,. Some suggestions for measuring predictive performance. J Pharmacokinet Biopharm 1981; 9: 503-512.
20. DuBois D, DuBois EF,. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 1916; 17: 863-871.
21. Boyd E,. The Growth of the Surface Area of the Human Body. Minneapolis: University of Minnesota Press, 1935.
22. Reich A, Beland B, Van Aken H,. Intravenous narcotics and analgesic agents. In:, Bissonnette B, Dalens B, eds. Pediatric Anesthesia. London: McGraw-Hill, 2002: 259-277.
23. Beal S, Sheiner LB, Boeckmann A, et al. NONMEM User's Guides. (1989-2009). Ellicott City, MD, USA: Icon Development Solutions, 2009.
24. Parke J, Holford NH, Charles BG,. A procedure for generating bootstrap samples for the validation of nonlinear mixed-effects population models. Comput Methods Programs Biomed 1999; 59: 19-29. (Pubitemid 29125558)
25. Holford NHG,. Wings for NONMEM Version 703 for NONMEM 7., 2010. Accessed 20 Sept 2011
26. FDA. Guidance for Industry. Pharmacokinetics in patients with impaired hepatic function: study design, data analysis, and impact on dosing and labeling. http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/ucm072123.pdf 2003. Accessed 20 Sept 2011
27. Anderson BJ, Allegaert K, Van den Anker JN, et al. Vancomycin pharmacokinetics in preterm neonates and the prediction of adult clearance. Br J Clin Pharmacol 2007; 63: 75-84. (Pubitemid 44902880)
28. Cella M, Zhao W, Jacqz-Aigrain EM, et al. Paediatric drug development: are population models predictive of pharmacokinetics across paediatric populations? Br J Clin Pharmacol 2011; 72: 454-464.
29. Lynn AM, Opheim KE, Tyler DC,. Morphine infusion after pediatric cardiac surgery. Crit Care Med 1984; 12: 863-866. (Pubitemid 15201266)
30. Nahata MC, Powell DA, Durrell DE, et al. Acetaminophen accumulation in pediatric patients after repeated therapeutic doses. Eur J Clin Pharmacol 1984; 27: 57-59. (Pubitemid 14033880)
31. Bray RJ, Beeton C, Hinton W, et al. Plasma morphine levels produced by continuous infusion in children. Anaesthesia 1986; 41: 753-755. (Pubitemid 16071343)
32. Bouwmeester NJ, van den Anker JN, Hop WC, et al. Age- and therapy-related effects on morphine requirements and plasma concentrations of morphine and its metabolites in postoperative infants. Br J Anaesth 2003; 90: 642-652. (Pubitemid 36592339)
33. Lynn AM, Nespeca MK, Opheim KE, et al. Respiratory effects of intravenous morphine infusions in neonates, infants, and children after cardiac surgery. Anesth Analg 1993; 77: 695-701. (Pubitemid 23291882)
34. Beasley SW, Tibballs J,. Efficacy and safety of continuous morphine infusion for postoperative analgesia in the paediatric surgical ward. Aust N Z J Surg 1987; 57: 233-237. (Pubitemid 17129275)
35. Hendrickson M, Myre L, Johnson DG, et al. Postoperative analgesia in children: a prospective study in intermittent intramuscular injection versus continuous intravenous infusion of morphine. J Pediatr Surg 1990; 25: 185-190; discussion 190-181.
36. Lynn A, Nespeca MK, Bratton SL, et al. Clearance of morphine in postoperative infants during intravenous infusion: the influence of age and surgery. Anesth Analg 1998; 86: 958-963. (Pubitemid 28198858)
37. Geiger K, Georgieff M, Lutz H,. Side effects of positive pressure ventilation on hepatic function and splanchnic circulation. Int J Clin Monit Comput 1986; 3: 103-106. (Pubitemid 17196834)
38. Richard C, Berdeaux A, Delion F, et al. Effect of mechanical ventilation on hepatic drug pharmacokinetics. Chest 1986; 90: 837-841. (Pubitemid 17196172)
39. Perkins MW, Dasta JF, DeHaven B,. Physiologic implications of mechanical ventilation on pharmacokinetics. DICP 1989; 23: 316-323. (Pubitemid 19102686)
40. Chay PC, Duffy BJ, Walker JS,. Pharmacokinetic-pharmacodynamic relationships of morphine in neonates. Clin Pharmacol Ther 1992; 51: 334-342.
41. Pokela ML, Olkkola KT, Seppala T, et al. Age-related morphine kinetics in infants. Dev Pharmacol Ther 1993; 20: 26-34. (Pubitemid 24169492)
42. Choonara I, Lawrence A, Michalkiewicz A, et al. Morphine metabolism in neonates and infants. Br J Clin Pharmacol 1992; 34: 434-437.
43. Mikkelsen S, Feilberg VL, Christensen CB, et al. Morphine pharmacokinetics in premature and mature newborn infants. Acta Paediatr 1994; 83: 1025-1028. (Pubitemid 24335766)
44. Wang C, Peeters MYM, Allegaert K, et al. Scaling clearance of propofol from preterm neonates to adults using an allometric model with a bodyweight-dependent maturational exponent [http://www.page-meeting.org/? abstract=1818 ]. PAGE 2010; 19. Accessed 20 Sept 2011
45. Bartelink IH, Boclens JJ, Bredius RGM, et al. Study of age-related pharmacokinetics of busulfan in a large cohort of children before transplant. 6th International Symposium on Measurement and Kinetics of in vivo Drug Effects. Noordwijkerhout, 2010.
46. Mahmood I,. Response to the comments of Drs. Anderson and Holford. Br J Clin Pharmacol 2011; 72: 521-523.
47. Vandenberghe H, Mac Leod S, Chinyanga H, et al. Pharmacokinetics of intravenous morphine in balanced anesthesia: studies in children. Drug Metab Rev 1983; 14: 887-903. (Pubitemid 14229908)
48. Dahlstrom B, Bolme P, Feychting H, et al. Morphine kinetics in children. Clin Pharmacol Ther 1979; 26: 354-365. (Pubitemid 10194677)
49. Hartley R, Green M, Quinn M, et al. Pharmacokinetics of morphine infusion in premature neonates. Arch Dis Child 1993; 69: 55-58. (Pubitemid 23232984)
50. Barrett DA, Barker DP, Rutter N, et al. Morphine, morphine-6-glucuronide and morphine-3-glucuronide pharmacokinetics in newborn infants receiving diamorphine infusions. Br J Clin Pharmacol 1996; 41: 531-537. (Pubitemid 26184674)
51. Barrett DA, Elias-Jones AC, Rutter N, et al. Morphine kinetics after diamorphine infusion in premature neonates. Br J Clin Pharmacol 1991; 32: 31-37.
52. Olkkola KT, Maunuksela EL, Korpela R, et al. Kinetics and dynamics of postoperative intravenous morphine in children. Clin Pharmacol Ther 1988; 44: 128-136.
53. Choonara IA, McKay P, Hain R, et al. Morphine metabolism in children. Br J Clin Pharmacol 1989; 28: 599-604. (Pubitemid 19273609)
54. Portenoy RK, Foley KM, Stulman J, et al. Plasma morphine and morphine-6-glucuronide during chronic morphine therapy for cancer pain: plasma profiles, steady-state concentrations and the consequences of renal failure. Pain 1991; 47: 13-19.
55. Murthy BR, Pollack GM, Brouwer KL,. Contribution of morphine-6- glucuronide to antinociception following intravenous administration of morphine to healthy volunteers. J Clin Pharmacol 2002; 42: 569-576. (Pubitemid 34438556)
56. Skarke C, Schmidt H, Geisslinger G, et al. Pharmacokinetics of morphine are not altered in subjects with Gilbert's syndrome. Br J Clin Pharmacol 2003; 56: 228-231. (Pubitemid 36981440)
57. Berkenstadt H, Mayan H, Segal E, et al. The pharmacokinetics of morphine and lidocaine in nine severe trauma patients. J Clin Anesth 1999; 11: 630-634. (Pubitemid 30064442)
58. Hoskin PJ, Hanks GW, Aherne GW, et al. The bioavailability and pharmacokinetics of morphine after intravenous, oral and buccal administration in healthy volunteers. Br J Clin Pharmacol 1989; 27: 499-505. (Pubitemid 19101158)
59. Murphy MR, Hug CC Jr,. Pharmacokinetics of intravenous morphine in patients anesthetized with enflurane-nitrous oxide. Anesthesiology 1981; 54: 187-192. (Pubitemid 11153973)
60. Hasselstrom J, Eriksson S, Persson A, et al. The metabolism and bioavailability of morphine in patients with severe liver cirrhosis. Br J Clin Pharmacol 1990; 29: 289-297. (Pubitemid 20129020)
61. Ward ME, Woodhouse A, Mather LE, et al. Morphine pharmacokinetics after pulmonary administration from a novel aerosol delivery system. Clin Pharmacol Ther 1997; 62: 596-609. (Pubitemid 28068063)
62. Holford N,. Dosing in children. Clin Pharmacol Ther 2010; 87: 367-370.
63. Beal SL,. Ways to fit a PK model with some data below the quantification limit. J Pharmacokinet Pharmacodyn 2001; 28: 481-504. (Pubitemid 33151426)
64. Ahn JE, Karlsson MO, Dunne A, et al. Likelihood based approaches to handling data below the quantification limit using NONMEM VI. J Pharmacokinet Pharmacodyn 2008; 35: 401-421.
65. Knibbe CA, Krekels EH, van den Anker JN, et al. Morphine glucuronidation in preterm neonates, infants and children younger than 3 years. Clin Pharmacokinet 2009; 48: 371-385.
66. Mahmood I,. Prediction of drug clearance in children from adults: a comparison of several allometric methods. Br J Clin Pharmacol 2006; 61: 545-557.
67. Lack JA, Stuart Taylor ME,. Calculation of drug dosage and body surface area of children. Br J Anaesth 1997; 78: 601-605. (Pubitemid 27226380)